(Q79799383)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17310362%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17310362%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

Graham C Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17310362%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

20 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17310362%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17310362%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17310362%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17310362%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

893-898

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17310362%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00467-006-0427-5

25 December 2019

exact match

0 references

cites work

A glomerular permeability factor produced by human T cell hybridomas

1 reference

12 December 2020

The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.

1 reference

12 December 2020

Infusion of Peripheral Blood Mononuclear Cell Products from Nephrotic Children Increases Albuminuria in Rats

1 reference

12 December 2020

B-cell compartment as the selective target for the treatment of immune thrombocytopenias

1 reference

12 December 2020

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

1 reference

12 December 2020

Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies

1 reference

12 December 2020

Pathogenic roles of B cells in human autoimmunity; insights from the clinic

1 reference

12 December 2020

Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab

1 reference

12 December 2020

Treatment of childhood autoimmune haemolytic anaemia with rituximab

1 reference

12 December 2020

B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience

1 reference

12 December 2020

Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome

1 reference

12 December 2020

A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia

1 reference

12 December 2020

IgM paraproteinaemic neuropathies.

1 reference

12 December 2020

Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse

1 reference

12 December 2020

Rituximab in the treatment of acquired factor VIII inhibitors

1 reference

12 December 2020

Nephrotic syndrome associated with T-cell lymphoma

1 reference

12 December 2020

Rituximab: mechanism of action and resistance

1 reference

12 December 2020

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

12 December 2020

Rituximab: mechanisms and applications

1 reference

12 December 2020

Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome

1 reference

12 December 2020

Hodgkin's disease and lipoid nephrosis

1 reference

12 December 2020

Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab

1 reference

12 December 2020

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

1 reference

12 December 2020

Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis

1 reference

12 December 2020

Rituximab therapy for steroid-dependent minimal change nephrotic syndrome

1 reference

12 December 2020

B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus

1 reference

12 December 2020

Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance

1 reference

12 December 2020

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

1 reference

12 December 2020

Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells

1 reference

12 December 2020

"The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma

1 reference

12 December 2020

Mechanisms of autoimmunity

1 reference

12 December 2020

Thymoma and minimal-change glomerulonephritis

1 reference

12 December 2020

B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab

1 reference

12 December 2020

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

12 December 2020

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

1 reference

12 December 2020

1 reference

12 December 2020

Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment

1 reference

12 December 2020

An open study of B lymphocyte depletion in systemic lupus erythematosus

1 reference

12 December 2020

Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease

1 reference

12 December 2020

Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome

1 reference

12 December 2020

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

1 reference

12 December 2020

Treatment of IgM antibody associated polyneuropathies using rituximab

1 reference

12 December 2020

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas.

1 reference

12 December 2020

Roles of B cells in rheumatoid arthritis

1 reference

12 December 2020

Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab

1 reference

12 December 2020

Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome

1 reference

12 December 2020

Monoclonal antibodies in the treatment of autoimmune cytopenias

1 reference

12 December 2020

Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome

1 reference

12 December 2020

Nephrotic syndrome with pollen hypersensitivity

1 reference

12 December 2020